Still controversial in France, fibromyalgia is recognized by the World Health Organization as a “disease” since 1992. It is a syndrome that is still poorly known and whose causes have not been scientifically established.
Her name is composed of the elements that characterize her: “fibrosis”, “myo” (muscle) and “algie” which means pain. It is characterized by chronic pain in specific areas of the body lasting more than three months. Unfortunately it can also be supplemented with sleep disorders, digestion, discomfort in the limbs. It can eventually be incapacitating and certainly affects the quality of life of patie
Like any disease, it is important in the case of fibromyalgia to establish an early diagnosis to ensure better care of patients. For this, we must consider the symptoms on the one hand, and the responses of the individual to an interrogation to identify and detect the signs of the disease.
Thus we must know elements of the life of the individual: suffering, pain, weakness, fatigue, problems in falling asleep and during sleep.
It is also important to identify the pain points on the body and especially to know if other pathologies are in action so that their effects are not mistaken for those characteristic of fibromyalgia. In addition, it is often necessary to carry out further medical investigations to confirm the presence of fibromyalgia.
A Californian company has developed a screening test for fibromyalgia, a very complex pathology to diagnose and still controversial, especially in France.
This “FM-Test” was recently revealed at the annual Rheumatology Congress in San Diego, USA. And it is basically a blood test. So, should we believe it?
This is a small revolution in the world of fibromyalgia: scientists have managed to create a screening test. It is intended for general practitioners, who are in the front line when it comes to diagnosing this controversial disease.
This is official because they published their discovery in the Journal of Evaluation in Clinical Practice . The idea is to relieve rheumatology practices and improve patient care.
The pains can be alleviated by our particular choices we can make in our diet. Of course, we do not yet know the scientific causes of this disease irrefutably, but studies tend to prove that certain nutrients can reduce this abnormal amplification of the pain felt that characterizes fibromyalgia.
Women are the most affected by this disease – still poorly known – which strikes up to 5% of the western population, according to the latest estimates. Many scientists see it as a chronic fatigue and besides in France it is still considered as a “syndrome” whereas it is a “disease” for the World Health Organization, and this since … 1992.
So what are his symptoms to recognize it?
Pain is first and foremost a warning mechanism for our body that helps us to become aware of dysfunctions, injuries or other attacks on our physical integrity. It prompts us especially to take corrective measures by obliging us by imperative sensations: the suffering, the fact of “having pain” pushes us to put an end to it.
The pain is often unobservable by others, but has particularly devastating consequences for those who experience it every day. Isolation, deconstruction, precariousness, loss of self-confidence.
This is what affects millions of people every day affected by this little-known disease: fibromyalgia. And the hidden proportions are gigantic: indeed, not less than 2 to 5% of Western populations. What’s more, health insurance attests that more than 80% of those affected are female.
Despite its global medical recognition, many doctors consider it a psychosomatic syndrome because the scientific cause is not yet clearly identified.
If the recognition of fibromyalgia is acquired since 2007 at the medical level, its legal qualification entails significant financial consequences.
Whether in the social security budget or in the affected families, it is the prerogative of the political sphere to guide choices and make the necessary decisions.
In France, fibromyalgia, whose medical and scientific causes are still poorly known, is described as “syndrome”, which means that patients are not reimbursed 100% for their care. In order to rectify this, a parliamentary report advocates classifying it as “disease”.
MEPs announce that this decision will “give credibility to the suffering” of patients. In other words, the law will recognize their suffering and force doctors to train themselves better in the treatment of pain.
In our country, it is estimated that it affects 1.2 to 2 million people who have “pain everywhere, all the time”. In order to put an end to different treatments, the rapporteur Patrice Carvalho recommends setting up a unified care path.
Fibromyalgia is characterized by chronic pain over a long period of time going to several years, a great fatigue without apparent cause and sleep disorders. The treatment of this disease is complex and is not yet fully recognized.
According to a report of the Parliamentary Inquiry Commission dated October 2016, it affects up to 5% of people in France, and mainly the female population, more than 80%. It strikes without discriminating all age groups: whether children, young adults or not, seniors.
As a result of better early diagnosis, the number of children affected by fibromyalgia has tended to increase recently.